SCHEMBL91450

SCHEMBL91450

Cc1cnc(N)c(C)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31619921 1.00
Acetic Acid SCHEMBL11485042 0.87 NOS3 (0.76)
SCHEMBL670767 0.79
SCHEMBL172774 0.79
SCHEMBL29765539 0.79
SCHEMBL11712416 0.75
SCHEMBL118541 0.75
SCHEMBL91444 0.75
SCHEMBL761151 0.75
SCHEMBL342702 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116355614-A Etching composition 安集微电子科技(上海)股份有限公司 2023-06-30 CN claimed
CN-115210339-A Etching solution for titanium nitride and molybdenum conductive metal wires 弗萨姆材料美国有限责任公司 2022-10-18 CN claimed
EP-4615839-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE Bristol-Myers Squibb Company (US) 2025-09-17 EP disclosed
US-20240180886-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE BRISTOL-MYERS SQUIBB COMPANY (US) 2024-06-06 US disclosed
WO-2024102794-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE BRISTOL-MYERS SQUIBB COMPANY (US) 2024-05-16 WO disclosed
US-20240010915-A1 Etching Solution For Titanium Nitride And Molybdenum Conductive Metal Lines VERSUM MATERIALS US, LLC (US) 2024-01-11 US disclosed
EP-3157929-B1 PYRAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF ARES TRADING SA (CH) 2023-12-13 EP disclosed
EP-4265607-A1 AMINOPYRIDINE COMPOUND AND APPLICATION THEREOF Medshine Discovery Inc. (CN) 2023-10-25 EP disclosed
US-20230303611-A1 SYNTHESIS OF AN ANTIVIRAL AZASUGAR TRIPHOSPHATE WILMINGTON TRUST, NATIONAL ASSOCIATION 2023-09-28 US disclosed
WO-2023146987-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. (US) 2023-08-03 WO disclosed
WO-2023146991-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. (US) 2023-08-03 WO disclosed
WO-1996018616-A1 SUBSTITUTED 2-AMINOPYRIDINES AS INHIBITORS OF NITRIC OXIDE SYNTHASE MERCK & CO., INC. (US) 1996-06-20 WO disclosed
EP-0508215-B1 Process for the preparation of 2-chloro-pyridines BAYER AG (DE) 1996-05-15 EP disclosed
EP-0508217-B1 Process for the preparation of 2-chloropyridines BAYER AG (DE) 1996-05-01 EP disclosed
EP-0618208-A1 Thiazolopyrimidine derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1994-10-05 EP disclosed
US-5283338-A Process for the preparation of 2-chloropyridines BAYER AKTIENGESELLSCHAFT (DE) 1994-02-01 US disclosed
EP-0508217-A1 Process for the preparation of 2-chloropyridines BAYER AG (DE) 1992-10-14 EP disclosed
EP-0508215-A1 Process for the preparation of 2-chloro-pyridines BAYER AG (DE) 1992-10-14 EP disclosed
US-4192944-A ANTIANAPHYLACTIC BRISTOL-MYERS COMPANY (US) 1980-03-11 US disclosed
US-4122274-A ANTIALLERGY BRISTOL-MYERS COMPANY (US) 1978-10-24 US disclosed